Viewing Study NCT07055451


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2025-12-31 @ 12:40 PM
Study NCT ID: NCT07055451
Status: RECRUITING
Last Update Posted: 2025-12-02
First Post: 2025-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV
Sponsor: Gilead Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module